Key result
Thrombolytic therapy can rarely cause diffuse pulmonary hemorrhage, which should be suspected in patients with respiratory distress, diffuse infiltrates, and an unexplained fall in hemoglobin.
Diffuse pulmonary hemorrhage is a rare but important complication of thrombolytic therapy for acute myocardial infarction that presents with respiratory distress, infiltrates, and falling hemoglobin.
Prompts suspicion for pulmonary hemorrhage post-thrombolysis with respiratory distress and falling hemoglobin; case report leaves open true frequency and predictors.
Diffuse pulmonary hemorrhage has rarely been reported as a complication of thrombolytic therapy. Recently, two patients who developed this complication were observed at our institution. This diagnosis should be considered in any post-thrombolytic patient with respiratory distress, diffuse pulmonary infiltrates, and an otherwise unexplained fall in hemoglobin.
No takes yet. Share an insight, caveat, or question.
Gopalakrishnan et al. (1997) studied this question. Thrombolytic therapy can rarely cause diffuse pulmonary hemorrhage, which should be suspected in patients with respiratory distress, diffuse infiltrates, and an unexplained fall in hemoglobin.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: